The company filed a lawsuit Wednesday in the US District Court for the District of Columbia challenging certain aspects of the Inflation Reduction Act’s Medicare Drug Price Negotiation Program, as well as the guidance issued by the Centers for Medicare & Medicaid Services implementing the law.
The program allows the US government to set the prices on some of the most widely used and ...